Peptides 101

Editors’ Note: We appreciate everyone who continues to share ideas and feedback! Email readers can reply to this email directly or anyone can email us at [email protected].

Or copy and paste this link to others: {{rp_refer_url}}

If you spend any time on health and wellness social media, you've almost certainly heard the word "peptides" in the last year. Maybe from a biohacker on a podcast, a fitness influencer on TikTok, or a friend at a dinner party who casually mentioned buying vials from a Chinese supplier. Peptides have burst out of niche bodybuilding circles and into mainstream conversation, but most people still have only the vaguest idea of what they actually are.

What exactly are Peptides?

At their simplest, peptides are short chains of amino acids, which are the same building blocks that make up proteins. The difference is length: proteins contain 50 or more amino acids strung together in long, complex sequences, while peptides are shorter, typically between 2 and 50 amino acids. That compact size makes them targeted in what they do.

Your body already produces thousands of peptides naturally. They act as signaling molecules which tell your cells to perform specific functions. Insulin, for example, is a peptide. So is oxytocin. Peptides regulate everything from hormone release and immune response to tissue repair and appetite.

Synthetic peptides are lab-made versions designed to mimic or amplify these natural signals. Some have been rigorously tested, FDA-approved, and prescribed for decades. Others are experimental compounds with promising animal data but almost no human trial evidence. The distinction matters enormously, and the current hype cycle tends to blur this.

How Ozempic opened the floodgates

GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are, technically, peptide-based medications. They mimic a naturally occurring gut peptide called glucagon-like peptide-1, which regulates appetite, insulin release, and gastric emptying.

The wild commercial success of these drugs did two critical things. First, it normalized self-injection. Millions of people who were once squeamish about needles became comfortable with weekly shots for weight management. Second, it demonstrated that peptides could produce dramatic, real-world health outcomes, creating a powerful proof of concept that enthusiasts have since extrapolated to dozens of other, far less tested compounds.

The GLP-1 boom also fueled a cost problem. Prescription drugs like Ozempic and Zepbound can run over $1,000 per month without insurance. In April 2025, the Trump administration announced that Medicare and Medicaid would not cover anti-obesity medications. That price gap is one of the primary forces pushing consumers toward cheaper, unregulated alternatives.

The China pipeline and a grey market

China is the world's dominant peptide manufacturing hub, and a massive grey market has emerged connecting Chinese factories directly to American consumers. According to U.S. customs data, imports of hormone and peptide compounds from China roughly doubled in 2025, reaching approximately $328 million in the first three quarters of the year alone, up from $164 million in the same period in 2024.

The mechanics are surprisingly simple. Peptides arrive as powders in small vials labeled "for research use only". Buyers then mix the powders with bacteriostatic water at home and inject themselves, often using insulin syringes purchased from Amazon. The economics are compelling: grey-market GLP-1 compounds can cost as little as $50 per vial, compared to $500-$1,000+ per month for brand-name prescriptions.

The products are sold through a patchwork of: dedicated websites, Telegram groups, Discord servers, and Reddit communities like "SemaglutideFreeSpeech." Some U.S.-based intermediaries import Chinese peptides, conduct third-party purity testing, and resell them at a markup. Others ship directly from overseas factories.

By the numbers:

$328 million: Chinese peptide imports to the U.S. in the first nine months of 2025

44%: Monthly increase in Chinese GLP-1 shipments from Dec. 2024 to Jan. 2025

~800%: Growth in online advertising for unauthorized peptides from 2022 to 2024

~100: Peptide-based drugs approved worldwide; most grey-market peptides are not among them

Pharmaceutical companies have been reluctant to invest in clinical trials for many peptides because they're relatively easy to synthesize and hard to patent. For biohackers and longevity enthusiasts, the grey market fills that vacuum.

The most popular peptides

BPC-157 (Body Protection Compound): Arguably the most hyped peptide in wellness circles right now, BPC-157 is derived from a protein found in human gastric juice. It's been shown to accelerate wound healing and protect tissues in animal studies. Online communities credit it with healing torn ligaments, repairing gut issues, and reducing inflammation. However, there are very few published human trials, and the World Anti-Doping Agency banned it in 2022. It is not FDA-approved for human use.

TB-500 (Thymosin Beta-4 fragment): A synthetic version of a naturally occurring peptide involved in tissue repair and cell migration. Often stacked with BPC-157 in what the internet calls the "wolverine stack" for its alleged supercharged healing properties. Like BPC-157, it has animal data but limited rigorous human evidence.

Semaglutide and Tirzepatide (GLP-1s): The FDA-approved drugs behind Ozempic, Wegovy, Mounjaro, and Zepbound. These are the gold standard for evidence-based peptide therapeutics. Oral formulations of semaglutide also reached the market, expanding access. Beyond weight loss, users have begun microdosing GLP-1s for reported effects on addictive behaviors. Clinical trials on microdosing don't yet exist.

CJC-1295 / Ipamorelin: A combination often marketed as a growth-hormone secretagogue, meaning it stimulates your body to produce more growth hormone. Popular in anti-aging and fitness communities. Clinical evidence is limited, and long-term safety in humans is not established.

Melanotan II: Known informally as the "Barbie peptide," melanotan II stimulates melanin production to darken the skin without sun exposure. It has significant side effect concerns, including nausea, elevated blood pressure, and changes to moles that could mask skin cancer detection.

Why you should care

Peptides are not a fad. They represent a genuinely important category of therapeutics that has already produced some of the most impactful drugs in modern medicine. 

There's a wide gap between FDA-approved peptide drugs backed by extensive clinical data and unregulated powders shipped from Chinese factories in vials marked "not for human use." The current moment is characterized by that gap: massive consumer demand colliding with limited regulation, inconsistent quality, and an evidence base that, for most popular peptides, simply isn't there yet.

If you're considering peptide therapy, the responsible path forward looks like this: work with a licensed physician, prioritize FDA-approved options where they exist, and treat bold claims from influencers and online communities with healthy skepticism. The science will likely catch up to the hype eventually, but it hasn't yet.

Or copy and paste this link to others: {{rp_refer_url}}

Current Referral Count: {{rp_num_referrals}}